Fiche publication
Date publication
novembre 2024
Journal
The Lancet. Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric
,
Pr BRIGAND Cécile
Tous les auteurs :
Classe JM, Meeus P, Hudry D, Wernert R, Quenet F, Marchal F, Houvenaeghel G, Bats AS, Lecuru F, Ferron G, Brigand C, Berton D, Gladieff L, Joly F, Ray-Coquard I, Durand-Fontanier S, Liberale G, Pocard M, Georgeac C, Gouy S, Guilloit JM, Guyon F, Costan C, Rousselet JM, de Guerké L, Bakrin N, Brument E, Martin E, Asselain B, Campion L, Glehen O,
Lien Pubmed
Résumé
Hyperthermic intraperitoneal chemotherapy (HIPEC) at interval cytoreductive surgery for ovarian cancer improves overall survival but its role in recurrent disease is uncertain. We aimed to compare outcomes in patients treated with or without HIPEC during surgery for recurrent ovarian cancer.
Référence
Lancet Oncol. 2024 11 13;:
